Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| IRB No. 114-86 | Other Identifier | City Hospital Renai IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study evaluated the feasibility and health effects of using augmented reality (AR) treadmill walking in older adults. Sixty community-dwelling adults aged 65 to 80 years were randomly assigned to either an AR treadmill group or a traditional treadmill group. Both groups participated in supervised walking sessions three times per week for twelve weeks. The study examined changes in mobility, balance, body composition, physiological responses, and participants' perceptions of the AR technology.
This randomized controlled trial evaluated the effects of augmented reality (AR) treadmill walking on mobility-related motor function, body composition, physiological responses, and technology acceptance among older adults. A total of 60 community-dwelling adults aged 65 to 80 years were randomly assigned to either an experimental group (AR treadmill walking) or a control group (traditional treadmill walking).
Participants in both groups engaged in supervised walking sessions three times per week for twelve weeks. Each session lasted 60 minutes, including a 10-minute warm-up, 40-minute treadmill walking, and a 10-minute cool-down. The AR treadmill (JOHNSON 8.1T) provided immersive visual environments and real-time feedback on physiological data. The control group used a standard treadmill (CHANSON CS-6630) without AR features.
Primary outcome measures included stride length, gait speed, and balance. Secondary outcomes included skeletal muscle mass, body fat mass, body fat percentage, heart rate, calorie expenditure, walking distance, and technology acceptance assessed by a validated questionnaire.
Statistical analysis included repeated-measures ANOVA, independent t-tests, and Pearson correlation analysis to examine group differences and associations between physiological responses and technology acceptance.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental: Augmented Reality Treadmill Walking | Experimental | Participants in this group performed treadmill walking using the JOHNSON 8.1T treadmill with Passport AR system. The device provided immersive visual environments (e.g., forest trails, hills) and real-time feedback on heart rate, speed, and distance. Each participant completed supervised walking sessions 3 times per week for 12 weeks, with each session lasting 60 minutes (10-minute warm-up, 40-minute walking, 10-minute cool-down). |
|
| Active Comparator: Traditional Treadmill Walking | Active Comparator | Participants in this group performed treadmill walking using the CHANSON CS-6630 treadmill, which provided standard speed, time, and distance tracking without augmented reality features. Each participant completed supervised walking sessions 3 times per week for 12 weeks, with each session lasting 60 minutes (10-minute warm-up, 40-minute walking, 10-minute cool-down). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Traditional Treadmill Walking | Device | Participants walked on a traditional treadmill with standard time, speed, and distance tracking, no AR features. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Stride Length | Average stride length (in centimeters) measured using the 2-Minute Walk Test (2MWT). | Baseline and after 12 weeks of intervention |
| Gait Speed | Walking speed (in meters per second) assessed during a 30-meter walk test. | Baseline and after 12 weeks of intervention |
| Balance (Timed Up and Go Test) | Time taken to complete the Timed Up and Go (TUG) test. Lower values indicate better balance. | Baseline and after 12 weeks of intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Skeletal Muscle Mass | Measured using bioelectrical impedance analysis (InBody 520). Unit: kg. | Baseline and after 12 weeks of intervention |
| Body Fat Mass | Measured using bioelectrical impedance analysis (InBody 520). Unit: kg. |
Not provided
Inclusion Criteria:
Community-dwelling adults aged 65 to 80 years
Able to walk independently without assistive devices
Cognitively intact and able to follow instructions
No prior use of augmented reality (AR) exercise programs within the past 3 months
Willing to participate in the study and provide informed consent
Exclusion Criteria:
Diagnosed with chronic conditions that impair mobility (e.g., cardiovascular disease, severe arthritis)
Severe visual or auditory impairments that affect interaction with AR equipment
Neurological or psychiatric disorders that may interfere with participation
Known susceptibility to motion sickness or discomfort with virtual environments (AR-induced discomfort)
Inability to complete the 12-week training protocol or attend scheduled assessments
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Fitness Center, National Taiwan College of Performing Arts | Taipei | No. 177, Section 2, Neihu Rd. | 244 | Taiwan |
Individual participant data (IPD) will not be shared due to privacy considerations and the small sample size of older adult participants. Additionally, data sharing was not included in the original study protocol or informed consent process. Therefore, public sharing of IPD is not permitted under the current ethical approval.
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Dec 15, 2024 | Jul 8, 2025 |
Not provided
Participants were randomly assigned to one of two parallel groups: an experimental group that received augmented reality treadmill walking training and a control group that received traditional treadmill walking training. Both groups participated in the same frequency and duration of exercise (3 sessions per week for 12 weeks), allowing direct comparison of intervention effects on cognitive function, body composition, and physiological responses.
Not provided
Not provided
No masking was used in this study. Due to the nature of the intervention (visible augmented reality equipment), participants, investigators, and outcome assessors were aware of group assignments.
Not provided
|
| JOHNSON 8.1T treadmill with Passport AR system | Device | Participants walked on an AR-integrated treadmill with immersive virtual environments and real-time feedback. |
|
| Baseline and after 12 weeks of intervention |
| Body Fat Percentage | Measured using bioelectrical impedance analysis (InBody 520). Unit: %. | Baseline and after 12 weeks of intervention |
| Heart Rate | Average heart rate monitored during each exercise session using treadmill sensors or wearable device. | During each session (12 weeks) |
| Calorie Expenditure | Calories burned per session, tracked by treadmill and validated device. | During each session (12 weeks) |
| Distance Walked | Total distance covered per session (in meters or kilometers). | During each session (12 weeks) |
| Technology Acceptance | Measured using a validated questionnaire based on the Technology Acceptance Model (TAM), including perceived ease of use, usefulness, and behavioral intention. | After 12 weeks of intervention |
| ICF_000.pdf |
| ID | Term |
|---|---|
| D060825 | Cognitive Dysfunction |
| D055948 | Sarcopenia |
| D051346 | Mobility Limitation |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D009133 | Muscular Atrophy |
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D001284 | Atrophy |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |
| D001519 | Behavior |
Not provided
Not provided